Actions of intrathecal diphtheria toxin-substance P fusion protein on models of persistent pain

Pain

Volumn 79, Issue 2-3, 1999, Pages 243-253

  Benoliel, Rafael ^a,b   Eliav, Eli ^b   Mannes, Andrew J ^a,c   Caudle, Robert M ^a   Leeman, Susan ^d   Iadarola, Michael J ^a  

^a Neuronal Gene Expression Unit   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytotoxins; Immunotoxins; Substance P

Indexed keywords

DIPHTHERIA TOXIN; HYBRID PROTEIN; SUBSTANCE P; SUBSTANCE P RECEPTOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; IMMUNOCYTOCHEMISTRY; INTRATHECAL DRUG ADMINISTRATION; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT;

ACUTE DISEASE; ANIMALS; CARRAGEENAN; CHRONIC DISEASE; CONSTRICTION, PATHOLOGIC; DIPHTHERIA TOXIN; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INJECTIONS, SPINAL; MALE; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; SCIATIC NERVE; SUBSTANCE P;

EID: 0033056376     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00170-5     Document Type: Article

References (48)

1. Abbadie C., Brown J.L., Mantyh P.W., Basbaum A.I. Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain. Neuroscience. 70:1996;201-209.
2. Allen B.J., Rogers S.D., Ghilardi J.R., Menning P.M., Kuskowski M.A., Basbaum A.I., Simone D.A., Mantyh P.W. Noxious cutaneous thermal stimuli induce a graded release of endogenous substance P in the spinal cord: imaging peptide action in vivo. J. Neurosci. 17:1997;5921-5927.
3. Andoh T., Nagasawa T., Kuraishi Y. Expression of tachykinin NK1 receptor mRNA in dorsal root ganglia of the mouse. Brain Res. Mol. Brain. Res. 35:1996;329-332.
4. Bennett G.J., Xie Y.K.A. Peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
5. Brown J.L., Liu H., Maggio J.E., Vigna S.R., Mantyh P.W., Basbaum A.I. Morphological characterization of substance P receptor-immunoreactive neurons in the rat spinal cord and trigeminal nucleus caudalis. J. Comp. Neurol. 356:1995;327-344.
6. Choi Y., Yoon Y.W., Na H.S., Kim S.H., Chung J.M. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain. 59:1994;369-376.
7. Draisci G., Iadarola M.J. Temporal analysis of increases in c-fos, preprodynorphin and proenkephalin mRNAs in rat spinal cord. Mol. Br. Res. 6:1989;31-37.
8. Duggan A.W., Hendry I.A., Morton C.R., Hutchison W.D., Zhao Z.Q. Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat. Brain Res. 451:1988;261-273.
9. Fisher C.E., Sutherland J.A., Krause J.E., Murphy J.R., Leeman S.E., VanderSpek J.C. Genetic construction and properties of a diphtheria toxin-related substance P fusion protein: in vitro destruction of cells bearing substance P receptors. Proc. Natl. Acad. Sci. USA. 93:1996;7341-7345.
10. Garland A.M., Grady E.F., Payan D.G., Vigna S.R., Bunnett N.W. Agonist-induced internalization of the substance P (NK1) receptor expressed in epithelial cells. Biochem. J. 303:1994;177-186.
11. Grady E.F., Garland A.M., Gamp P.D., Lovett M., Payan D.G., Bunnett N.W. Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor. Mol. Biol. Cell. 6:1995;509-524.
12. Haley J.E., Sullivan A.F., Dickenson A.H. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res. 518:1990;218-226.
13. Hershey A.D., Polenzani L., Woodward R.M., Miledi R., Krause J.E. Molecular and genetic characterization, functional expression, and mRNA expression patterns of a rat substance P receptor. Ann. N.Y. Acad. Sci. 632:1991;63-78.
14. Hunt S.P., Pini A., Evan G. Induction of c-fos like protein in spinal cord following sensory stimulation. Nature (Lond.). 328:1987;623-634.
15. Iadarola M.J., Caudle R.M. Good pain, bad pain. Science. 278:1997;239-240.
16. Iadarola M.J., Kim D.J., Caudle R.M. Analysis of C-terminal splice variants of the NMDA NR1 subunit in spinal cord using sequence specific antisera. Soc. Neurosci. Abstr. 22:1996;1196.
17. Iadarola M.J., Douglass J., Civelli O., Naranjo J.R. Differential activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridization. Brain Res. 455:1988;205-212.
18. Kato Y., Sugiyama Y. Targeted delivery of peptides, proteins and genes by receptor mediated endocytosis. Crit. Rev. Ther. Drug Carrier Syst. 14:1997;287-331.
19. Krause J.E., Bu J.-Y., Takeda Y., Blount P., Raddatz R., Sachais B.S., Chou K.B., Takeda J., McCarson K., DiMaggio D. Structure expression and second messenger-mediated regulation of the human and rat substance P receptors and their genes. Regul. Pept. 46:1993;59-66.
20. Leppla, S.H., Anthrax Toxins. In: J. Moss, B. Iglewski, M. Vaughan and A.T. Tu (Eds.), Handbook of Natural Toxins Vol. 8. Bacterial Toxins and virulence factors in disease, Marcel Dekker, New York, 1995, pp. 543-572.
21. Liu, H., Brown, J.L., Jasmin, L., Maggio, J.E., Vigna, S.R., Mantyh, P.W. and Basbaum, A.I., Synaptic relationship between substance P and the substance P receptor: light microscopic and electron microscopic characterization of the mismatch between neuropeptides and their receptors, Proc. Natl. Acad. Sci. USA., 91 (1994a) 1009-1013.
22. Liu, H., Wang, H., Sheng, M., Jan, L.Y., Jan, Y.N. and Basbaum, A.I., Evidence for the presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn, Proc. Natl. Acad. Sci. USA., 91 (1994b) 8383-8387.
23. Liu H., Mantyh P.W., Basbaum A.I. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature. 386:1997;721-724.
24. McCarson K.E., Krause J.E. NK-1 and NK-2 type tachykinin receptor mRNA expression in the rat spinal cord dorsal horn is increased during adjuvant or formalin-induced nociception. J. Neurosci. 14:1994;712-720.
25. Mantyh P.W., Gates T., Mantyh C.R., Maggio J.E. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J. Neurosci. 9:1989;258-279.
26. Mantyh, P.W., Allen, B.J., Ghilardi, J.R., Rogers, S.D., Mantyh, C.R., Liu, H., Basbaum, A.I., Vigna, S.R. and Maggio, J.E., Rapid endocytosis of a G protein-coupled receptor: substance P-evoked internalization of its receptor in the rat striatum in vivo, Proc. Natl. Acad. Sci. USA, 92 (1995a) 2622-2626.
27. Mantyh, P.W., De Master, E., Malhotra, A., Ghilardi, J.R., Rogers, S.D., Mantyh, C.R., Liu, H., Basbaum, A.I., Vigna, S.R., Maggio, J.E. and Simone, D.A., Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation, Science, 268 (1995b) 1629-1632.
28. Mantyh P.W., Rogers S.D., Honore P., Allen B.J., Ghilardi J.R., Li J., Basbaum A.I., Daughters R.S., Lappi D.A., Wiley R.G., Simone D.A. Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science. 278:1997;275-283.
29. Mellstrom B., Iadarola M.J., Yang H.-Y.T., Costa E. Inhibition of met5-enkephalin-arg6-phe7 degradation by inhibition of dipeptidylcarboxypeptidase. J. Pharmacol. Exp. Ther. 239:1986;174-178.
30. Otsuka M., Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73:1993;229-308.
31. Pappenheimer A.M. Jr. Diphtheria toxin. Annu. Rev. Biochem. 46:1977;69-94.
32. Pastan I., Chaudhary V., Fitzgerald D.J. Recombinant toxins as novel therapeutic agents. Annu. Rev. Biochem. 61:1992;331-354.
33. Quinn J.P., Takimoto M., Iadarola M.J., Holbrook N., Levens D. Distinct factors bind the AP1 consensus sites in gibbon ape leukemia virus and simian virus 40 enhancers. J. Virol. 63:1989;1737-1742.
34. Sato K., Kiyama H., Park H.T., Tohyama M. AMPA, KA and NMDA receptors are expressed in the rat DRG neurons. NeuroReport. 4:1993;1263-1265.
35. Schaffer M.K.H., Nohr D., Krause J.E., Weihe E. Inflammation-induced upregulation of NK1 receptor mRNA in dorsal horn neurons. NeuroReport. 4:1993;1007-1010.
36. Skidgel R.A., Engelbrecht S., Johnson A.R., Erdos E.G. Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase. Peptides. 5:1984;769-776.
37. Skilling S.R., Smullin D.H., Larson A.A. Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation. J. Neurochem. 51:1988;127-132.
38. Sugihara H., Moriyoshi K., Ishii T., Masu M., Nakanishi S. Structures and properties of seven isomorms of the NMDA receptor generated by alternative splicing. Biochem. Biophys. Res. Comm. 185:1992;826-832.
39. Sweeney, E.B. and Murphy. J.R., Diphtheria toxin-based receptor-specific chimaeric toxins as targeted therapies. In D.K. Apps and K.F. Tipton (Eds.), Essays in Biochemistry, Portland Press, Portland, OR, 1995, 119-130.
40. Tal M., Bennett G.J. Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nerve. Pain. 57:1994;375-382.
41. Unger T., Ganten D., Lang R.E., Scholkens B.A. Central actions of converting enzyme inhibitors in animal experiments. Prog. Pharmacol. 5:1984;51-68.
42. Vigna S.R., Bowden J.J., McDonald D.M., Fisher J., Okamoto A., McVey D.C., Payan D.G., Bunnett N.W. Characterization of antibodies to the rat substance P (NK-1) receptor and to a chimeric substance P receptor expressed in mammalian cells. J. Neurosci. 14:1994;834-845.
43. Watling, K.J., Kebabian, J.W. and Neumeyer, J.L., The RBI Handbook of Receptor Classification and Signal Transduction, Research Biochemicals, Massachussets, 1995, pp. 124-125.
44. Wiley R.G. Targeting toxins to neural antigens and receptors. Can. Biol. 7:1996;71-77.
45. Wiley R.G., Lappi D.A. Destruction of neurokinin-1 receptor expressing cells in vitro and in vivo using substance P-saporin in rats. Neurosci. Lett. 230:1997;97-100.
46. Youle R.J. Immunotoxins for central nervous system malignancy. Can. Biol. 7:1996;65-70.
47. Young S.T., Porrino L.J., Iadarola M.J. Cocaine induces striatal c-fos-immunoreactive protein via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. USA. 88:1991;1291-1295.
48. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals (editorial). Pain. 16:1983;109-110.